Dave Muoio

August 30, 2018
Otsuka Pharmaceuticals and Proteus Digital Health’s sensor-carrying pill Abilify MyCite is on its way to US patients thanks to a new collaboration agreement between Otsuka and Magellan Health. Announced this morning by the pharmaceutical company, the rollout will initially be limited to give Otsuka and Magellan a better idea of how best to deploy the technology at scale. “We are eager for...
August 30, 2018
Patient-centered care has become a focal point for providers looking to prove the value of their care. Many systems are looking to new technologies and disruptive, consumer-facing services, yet it’s not always clear whether these moves are appealing to each party. “For us, a lot of the challenge has been the definition for patient-centered care,” Blix Rice, vice president of innovation and...
August 29, 2018
This week virtual care provider Teladoc Health was busy, releasing news about a new product launch and a separate good will initiative. First was yesterday’s launch of Partners HealthCare On Demand, a virtual urgent care service collaboration between the telehealth company and Partners HealthCare. Delivered through web and mobile devices, the video-based service is first being rolled out to the...
August 29, 2018
Sempre Health, a San Francisco-based company that uses monetary incentives and pricing to encourage healthy behaviors, announced today that it has obtained $8 million in Series A financing. Rethink Impact was the lead investor, and was joined by Social Capital and other unnamed backers. “We are incredibly excited to invest in Sempre Health as it uses its core technology to tackle the nearly $300...
August 28, 2018
Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public. Published today in npj Digital Medicine, this 900-patient investigation showed that the IDx-Dr system for autonomous detection of diabetic retinopathy “robustly exceeded the pre-specified primary endpoint goals” and is able to...
August 28, 2018
Last week Renovia, maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy, announced the closure of a $32.3 million Series B equity round and an additional $10 million of debt financing. The round was led by Perceptive Advisors and Ascension Ventures, with additional participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF...
August 27, 2018
A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not. The investigation was conducted by a group of Australian researchers, and included a sample of 163 adults participants with an average age of roughly 58 years. Presented this week at the European Society of...
Cognoa child development assessment app for autism
August 27, 2018
In May, a pair of studies were published in the journals Autism Research and the Journal of the American Medical Informatics Association (JAMIA) that evaluated Cognoa’s artificial intelligence-based tool for early identification of autism in children. While both investigations suggest that the tool’s performance significantly exceeded those of other standardized screeners, comparing the two...
August 24, 2018
23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports. While the raw data will remain available to clinical research partners such as GlaxoSmithKline, which invested $300 million this year to gain access to the genetic testing startup’s DNA database for drug...
August 23, 2018
Psychiatry has long stood as one of the more subjective areas of care, but new technologies and large-scale data generation and analysis may offer a more quantifiable approach to mental health treatment. In a recently published perspective, a group of Verily researchers and Former FDA Commissioner Dr. Robert Califf called for the psychiatric field to embrace digital sensors and the data sciences...